Gastroenterology
Volume 132, Issue 3 , Pages 982-993 , March 2007

Sex Steroid Regulation of Macrophage Migration Inhibitory Factor in Normal and Inflamed Colon in the Female Rat

  • Eric Houdeau

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France
    • Corresponding Author InformationAddress reprint requests to: Eric Houdeau, PhD, Neuro-Gastroenterology and Nutrition Unit, Institut National de la Recherche Agronomique, 180 Chemin de Tournefeuille, BP 3, 31931 Toulouse cedex 9, France. fax: (33) 5 61 28 51 45.
    • ,
  • Raphael Moriez

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France
    • ,
  • Mathilde Leveque

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France
    • ,
  • Christel Salvador–Cartier

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France
    • ,
  • Aurelie Waget

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France
    • ,
  • Lin Leng

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, Connecticut
    • ,
  • Lionel Bueno

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France
    • ,
  • Richard Bucala

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, Connecticut
    • ,
  • Jean Fioramonti

      Affiliations

    • Neuro-Gastroenterology & Nutrition Unit, Institut National de la Recherche Agronomique, Toulouse, France

Received 30 March 2006 ,Accepted 27 November 2006.

References 

  1. Weber AM, Ziegler C, Belinson JL, Mitchinson AR, Widrich T, Fazio V. Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol. 1995;86:843–847
  2. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998;93:1867–1872
  3. Maunder R, Toner B, de Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol. 1999;13:728–732
  4. Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004;39:365–373
  5. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559–1568
  6. Gurbuz AK, Gurbuz B, Salas L, Rosenshein NB, Donowitz M, Giardiello FM. Premarin-induced ischemic colitis. J Clin Gastroenterol. 1994;19:108–111
  7. Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther. 2005;22:309–315
  8. Gunal O, Oktar BK, Ozcinar E, Sungur M, Arbak S, Yegen B. Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats. Inflammation. 2003;27:351–359
  9. Harnish DC, Albert LM, Leathurby Y, Eckert AM, Ciarletta A, Kasaian M, et al. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2004;286:118–125
  10. Verdu EF, Deng Y, Bercik P, Collins SM. Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2002;283:G27–G36
  11. Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology. 1975;96:219–226
  12. Faas MM, Bakker WW, Valkhof N, van der Horst MC, Schuiling GA. Reproductive condition and the low-dose endotoxin-induced inflammatory response in rats (Glomerular influx of inflammatory cells and expression of adhesion molecules). Biol Reprod. 1997;56:1400–1406
  13. Hellings PW, Vandekerckhove P, Claeys R, Billen J, Kasran A, Ceuppens JL. Progesterone increases airway eosinophilia and hyper-responsiveness in a murine model of allergic asthma. Clin Exp Allergy. 2003;33:1457–1463
  14. Jain SK, Kannan K, Prouty L, Jain SK. Progesterone, but not 17β-estradiol, increases TNF-α secretion in U937 monocytes. Cytokine. 2004;26:102–105
  15. Gillgrass AE, Fernandez SA, Rosenthal KL, Kaushic C. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J Virol. 2005;79:3107–3116
  16. Maaser C, Eckmann L, Paesold G, Kim HS, Kagnoff MF. Ubiquitous distribution of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology. 2002;122:667–680
  17. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791–800
  18. de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol. 2001;2:1061–1066
  19. Murakami H, Akbar SMF, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest. 2001;31:337–343
  20. Murakami H, Akbar SMF, Matsui H, Horiike N, Onji M. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol. 2002;128:504–510
  21. Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology. 2002;123:256–270
  22. Ohkawara T, Miyashita K, Nishihira J, Mitsuyama K, Takeda H, Kato M, et al. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis. Clin Exp Immunol. 2005;140:241–248
  23. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994;78:1895–1902
  24. Bouman A, Moes H, Heineman MJ, de Leij LF, Faas MM. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil Steril. 2001;76:555–559
  25. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol. 2004;189:404–412
  26. Speyer CL, Rancilio NJ, McClintock SD, Crawford JD, Gao H, Sarma JV, et al. Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol. 2005;288:C881–C890
  27. Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest. 2003;111:1309–1318
  28. Hardman MJ, Waite A, Zeef L, Burow M, Nakayama T, Ashcroft GS. Macrophage migration inhibitory factor: a central regulator of wound healing. Am J Pathol. 2005;167:1561–1574
  29. Makita H, Nishimura M, Miyamoto K, Nakano T, Tanino Y, Hirokawa J, et al. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med. 1998;158:573–579
  30. Houdeau E, Larauche M, Monnerie R, Bueno L, Fioramonti J. Uterine motor alterations and estrous cycle disturbances associated with colonic inflammation in the rat. Am J Physiol Regul Integr Comp Physiol. 2005;288:R630–R637
  31. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity (Assessment of inflammation in rat and hamster models). Gastroenterology. 1984;87:1344–1350
  32. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol. 1995;269:G119–G125
  33. Vongher JM, Frye CA. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol Biochem Behav. 1999;64:777–785
  34. Mazelin L, Theodorou V, Fioramonti J, Bueno L. Vagally dependent protective action of calcitonin gene-related peptide on colitis. Peptides. 1999;20:1367–1374
  35. Improta G, Carpino F, Petrozza V, Guglietta A, Tabacco A, Broccardo M. Central effects of selective NK1 and NK3 tachykinin receptor agonists on two models of experimentally-induced colitis in rats. Peptides. 2003;24:903–911
  36. Kats R, Al-Akoum M, Guay S, Metz C, Akoum A. Cycle-dependent expression of macrophage migration inhibitory factor in the human endometrium. Hum Reprod. 2005;20:3518–3525
  37. Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut. 1992;33:773–778
  38. McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut. 1998;42:214–219
  39. Rojas-Cartagena C, Flores I, Appleyard CB. Role of tumor necrosis factor receptors in an animal model of acute colitis. Cytokine. 2005;32:85–93
  40. Aloisi AM, Pari G, Ceccarelli I, Vecchi I, Ietta F, Lodi L, et al. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain. 2005;115:142–151
  41. Vera PL, Meyer-Siegler KL. Anatomical location of macrophage migration inhibitory factor in urogenital tissues, peripheral ganglia and lumbosacral spinal cord of the rat. BMC Neurosci. 2003;4:17–26
  42. Chalimoniuk M, King-Pospisil K, Metz CN, Toborek M. Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons. Neuroscience. 2006;139:1117–1128
  43. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation. Eur J Cancer. 2003;39:1251–1258
  44. Oshima CT, Wonraht DR, Catarino RM, Mattos D, Forones NM. Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology. 1999;46:3155–3158
  45. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, et al. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A. 2006;103:2959–2964
  46. Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G, et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology. 2005;129:1485–1503
  47. Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol. 1999;93:880–888
  48. Salzman AL, Linn SC, Szabo C. Progesterone inhibits inducible nitric oxide synthase mRNA expression in human intestinal epithelial cells. Int J Mol Med. 2000;6:209–216
  49. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I, Matsuyama T, et al. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis. Hum Reprod. 2005;20:2004–2013
  50. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2000;6:21–33
  51. Arai Y, Takanashi H, Kitagawa H, Okayasu I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine. 1998;10:890–896
  52. Schreiber S, Nikolaus S, Hampe J, Hamling J, Koop I, Groessner B, et al. Tumor necrosis factor α and interleukin 1β in relapse of Crohn’s disease. Lancet. 1999;353:459–461
  53. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, et al. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest. 1990;86:972–980
  54. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clin Exp Immunol. 1993;94:174–181
  55. Nikolaus S, Raedler A, Kuhbacker T, Sfikas N, Folsch UR, Schreiber S. Mechanisms in failure of infliximab for Crohn’s disease. Lancet. 2000;356:1475–1479
  56. Rutgeerts P, D’Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology. 1999;117:761–769
  57. Huang XR, Chun Hui CW, Chen YX, Wong BC, Fung PC, Metz C, et al. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology. 2001;121:619–630
  58. Roger T, Chanson AL, Knaup-Reymond M, Calandra T. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol. 2005;35:3405–3413
  59. Koebernick H, Grode L, David JR, Rohde W, Rolph MS, Mittrucker HW, et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc Natl Acad Sci U S A. 2002;99:13681–13686
  60. Powell ND, Papenfuss TL, McClain MA, Gienapp IE, Shawler TM, Satoskar AR, et al. Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis. J Immunol. 2005;175:5611–5614
  61. Yang N, Nikolic-Paterson DJ, Ng YY, Mu W, Metz C, Bacher M, et al. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production. Mol Med. 1998;4:413–424

 Supported by the Institut National de la Recherche Agronomique (INRA).

PII: S0016-5085(06)02678-3

doi: 10.1053/j.gastro.2006.12.028

Gastroenterology
Volume 132, Issue 3 , Pages 982-993 , March 2007

Article Tools

* Image Usage & Resolution